This site uses cookies to provide you with a more responsive and personalised service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print page

Life Sciences and Health Care Industry

Life science and Health careDeloitte Global Life Sciences and Health Care Practice
Deloitte Global has 5,400 professionals serving the Life Sciences and Health Care industry. Deloitte’s clients include all of the 10 largest global pharmaceutical manufacturers, nine of the 10 largest global medical equipment manufacturers, eight of the 10 largest global biotechnology companies and 82% of the Life Sciences and Health Care in the Fortune Global 500 list.

Network of Deloitte Global Life Sciences and Health Care industry

  • Business network covers the world's 60 countries
  • The team consists of 5,400 industry professionals including 1,380 senior partners, principals and directors
  • The cross-regional and cross-functional professionals work As One to provide the clients with state of art audit, tax, enterprise risk management services, financial advisory services and consulting services

Deloitte China Life Sciences and Health Care practice
In China, Deloitte has an elite team of over 350 bilingual professionals. Our diverse cultural backgrounds, professional knowledge and local understanding of industry-specific challenges within China enable our team to effectively communicate with clients, thoroughly understand their business needs and provide comprehensive solutions that meet their goals.

Deloitte China Life Sciences and Health Care practice covers the following three sectors:

  • Life Sciences
    • Pharmaceuticals
    • Biotechnology
    • Medical equipment
    • Service companies
      • Drug distribution
      • CRO
  • Health Care providers
    • Hospitals
    • Professional service providers
    • Outpatient facilities
    • Long term care
  • Health Plans

Featured insight

  • Health care reform and life sciences: Threat, opportunity or both?
    Health care reform and life sciences: Threat, opportunity or both?
    Exploring how nearly 300 senior life science executives are meeting the challenges and opportunities of global health care reforms, and the national differences through case studies of China, Brazil and Germany.
  • The next phase: Opportunities in China's pharmaceuticals market
    This report focuses in particular on pharmaceuticals companies, both domestic and foreign, and their activities in the China market—all from the viewpoint of prospective investors.
  • 2011 survey of health care consumers in China
    China joined the survey for the first time. A study of Chinese health care consumers' attitudes, behaviors and unmet needs in six key areas.
  • 2011 global survey of health care consumers
    Explore the findings from Deloitte's fourth consumer survey, based on the findings from 15,000 consumers in 12 countries.
  • China Life Sciences and Health Care market
    Opportunities, challenges and implications for the Life Sciences and Health Care industry in China
  • Contract Risk and Compliance: Know your risks
    Emerging markets, third-party intermediaries, and the life sciences industry.

 

 

 

Contact us

  • Yvonne Wu
    Enterprise Risk Services Partner; National Industry Leader, Life Sciences and Health Care
  • ExternalURL
    Jill Zhu
    Program Assistant Manager, Life Sciences and Health Care

Featured content

  • ExternalURL
    Social networks for life sciences
    Online social networks are everywhere and life sciences is no exception
  • ExternalURL
    Breaking down the wall
    Integrating clinical development with commercial operations
  • ExternalURL
    R&D leadership development in today's environment
    Understanding the business of science
  • ExternalURL
    Services thinking for life sciences
    A strategic approach to clinical trial start ups
  • ExternalURL
    Innovation indicators for health care in emerging countries
    Understanding and promoting innovation in emerging markets
  • ExternalURL
    Private health care providers: The prognosis for growth
    New study examines increasing wealth of a country and the demand for healthcare
  • ExternalURL
    Large health and medical insurance provider implements Enterprise information management system
    Case study
  • ExternalURL
    Strategies and approaches for health care providers to achieve and maintain a competitive advantage
    Help your organization increase market share

Related links

  • ExternalURL
    Deloitte Global Life Sciences and Health Care
    Global reach that you can count on
  • ExternalURL
    Deloitte China services
    Our full range of services
© 2013 Deloitte Touche Tohmatsu in Hong Kong, Deloitte Touche Tohmatsu in Macau, and Deloitte Touche Tohmatsu Certified Public Accountants LLP in the Chinese Mainland. All rights reserved.

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee, and its network of member firms, each of which is a legally separate and independent entity. Please see www.deloitte.com/cn/en/about for a detailed description of the legal structure of Deloitte Touche Tohmatsu Limited and its member firms.
Share your comments

 

About this site

Stay connected